These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background. Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830 [TBL] [Abstract][Full Text] [Related]
18. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737 [TBL] [Abstract][Full Text] [Related]
19. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Lu QL; Mann CJ; Lou F; Bou-Gharios G; Morris GE; Xue SA; Fletcher S; Partridge TA; Wilton SD Nat Med; 2003 Aug; 9(8):1009-14. PubMed ID: 12847521 [TBL] [Abstract][Full Text] [Related]
20. By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping. Mitrpant C; Fletcher S; Iversen PL; Wilton SD J Gene Med; 2009 Jan; 11(1):46-56. PubMed ID: 19006096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]